Related Experiment Video
Updated: Aug 29, 2026

Characterizing DNA Repair Processes at Transient and Long-lasting Double-strand DNA Breaks by Immunofluorescence Microscopy
Published on: June 8, 2018
Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair
Junran Zhang1, Henning Willers, Zhihui Feng
1Department of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, 149 13th Street, Charlestown, MA 02129, USA.
Abstract:
The pathway determining malignant cellular transformation, which depends upon mutation of the BRCA1 tumor suppressor gene, is poorly defined. A growing body of evidence suggests that promotion of DNA double-strand break repair by homologous recombination (HR) may be the means by which BRCA1 maintains genomic stability, while a role of BRCA1 in error-prone nonhomologous recombination (NHR) processes has just begun to be elucidated. The BRCA1 protein becomes phosphorylated in response to DNA damage, but the effects of phosphorylation on recombinational repair are unknown. In this study, we tested the hypothesis that the BRCA1-mediated regulation of recombination requires the Chk2- and ATM-dependent phosphorylation sites. We studied Rad51-dependent HR and random chromosomal integration of linearized plasmid DNA, a subtype of NHR, which we demonstrate to be dependent on the Mre11-Rad50-Nbs1 complex. Prevention of Chk2-mediated phosphorylation via mutation of the serine 988 residue of BRCA1 disrupted both the BRCA1-dependent promotion of HR and the suppression of NHR. Similar results were obtained when endogenous Chk2 kinase activity was inhibited by expression of a dominant-negative Chk2 mutant. Surprisingly, the opposing regulation of HR and NHR did not require the ATM phosphorylation sites on serines 1423 and 1524. Together, these data suggest a functional link between recombination control and breast cancer predisposition in carriers of Chk2 and BRCA1 germ line mutations. We propose a dual regulatory role for BRCA1 in maintaining genome integrity, whereby BRCA1 phosphorylation status controls the selectivity of repair events dictated by HR and error-prone NHR.
Insights
BRCA1 phosphorylation by Chk2 controls DNA repair pathways, promoting accurate homologous recombination (HR) and suppressing error-prone nonhomologous recombination (NHR). This dual role is crucial for maintaining genomic stability and understanding breast cancer predisposition.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- The BRCA1 tumor suppressor gene is critical in preventing malignant transformation, with its role in DNA repair pathways being actively investigated.
- BRCA1 is known to influence DNA double-strand break repair, particularly homologous recombination (HR), but its precise mechanisms and regulation by phosphorylation are unclear.
- Understanding BRCA1's function in both accurate (HR) and error-prone (nonhomologous recombination - NHR) repair is essential for comprehending genomic stability and cancer development.
Purpose of the Study:
- To investigate the role of Chk2- and ATM-dependent phosphorylation sites in BRCA1-mediated regulation of DNA recombination.
- To determine how BRCA1 phosphorylation affects homologous recombination (HR) and nonhomologous recombination (NHR) pathways.
- To explore the link between BRCA1, Chk2, ATM, and breast cancer predisposition.
Main Methods:
- Studied Rad51-dependent HR and random chromosomal integration of plasmid DNA (a subtype of NHR) dependent on the Mre11-Rad50-Nbs1 complex.
- Utilized site-directed mutagenesis to prevent Chk2-mediated phosphorylation of BRCA1 at serine 988.
- Inhibited endogenous Chk2 kinase activity using a dominant-negative Chk2 mutant.
Main Results:
- Mutation of BRCA1 serine 988, preventing Chk2 phosphorylation, disrupted BRCA1's promotion of HR and suppression of NHR.
- Inhibition of Chk2 kinase activity yielded similar results to the serine 988 mutation, affecting both HR and NHR.
- Opposing regulation of HR and NHR by BRCA1 did not require ATM phosphorylation sites (serines 1423 and 1524).
Conclusions:
- BRCA1 phosphorylation status, particularly via Chk2, is a key regulator controlling the balance between accurate HR and error-prone NHR.
- These findings establish a functional link between recombination control, BRCA1, and Chk2, impacting breast cancer predisposition in mutation carriers.
- BRCA1 plays a dual role in maintaining genome integrity by dictating the selectivity of DNA repair events through its phosphorylation-dependent regulation of HR and NHR.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Restarting Stalled Replication Forks
Fixing Double-strand Breaks
Fixing Double-strand Breaks
Homologous Recombination

